Prevention of CKD in patients with renal stone disease - à¹à¸£à¸à¸à¸¢à¸²à¸à¸²à¸¥ ...
Prevention of CKD in patients with renal stone disease - à¹à¸£à¸à¸à¸¢à¸²à¸à¸²à¸¥ ... Prevention of CKD in patients with renal stone disease - à¹à¸£à¸à¸à¸¢à¸²à¸à¸²à¸¥ ...
Meta Analysis: Lower systolic BP results in slower ratesof decline in GFR in Diabetics and Non-DiabeticsSBP (mmHg)130 134 138 142 146 150 154 170 1800GFR ( (mL mL/min/year)-2-4-6-8-10-12-14r = 0.69; P < .05UntreatedHTNParving HH, et al. Br Med J. 1989. Moschio G, et al. N Engl J Med. 1996.Viberti GC, et al. JAMA. 1993.Bakris GL, et al. Kidney Int. 1996.Klahr S, et al. N Eng J Med. 1994. Bakris GL. Hypertension. 1997.Hebert L, et al. Kidney Int. 1994. The GISEN Group. Lancet. 1997.Lebovitz H, et al. Kidney Int. 1994.Bakris GL, et al. Am J Kidney Dis. 2000;36(3):646-661.661.
Drug for BP Control in CKDเปาหมายคนปกติเปาหมายในหญิงตั้งครรภPre-hypertensiveความดันโลหิตสูงSystolic BP< 130110-129129130-139139> 140Diastolic BP< 8065-7980-8989> 90การรักษาปรับวิถีชีวิต3 เดือนยาลดความดันโลหิต และปรับวิถีชีวิตหมายหตุยังคงเดิม ใหยาลดความดันโลหิต
- Page 1 and 2: Update on CKD PreventionStrategies
- Page 3 and 4: Etiology of End-Stage Renal Disease
- Page 5 and 6: Natural History of DNCardiovascular
- Page 9 and 10: Risk factors for DN Poor glycemic c
- Page 12 and 13: American Diabetic Association2005 (
- Page 14 and 15: Microalbuminuria (MAU) ทําก
- Page 16 and 17: Glycemic Control - Intervention Stu
- Page 18 and 19: HBA1c ผูปวยที่ค
- Page 22 and 23: Hypertension control ในผู
- Page 24 and 25: Goal BP Recommendations for Patient
- Page 26 and 27: SummaryType 1 DMNormo-albuminuriaTy
- Page 28 and 29: Hyperlipidemiaอายุผูป
- Page 30 and 31: งดสูบบุหรี่Sm
- Page 32: ขอบคุณครับ
Meta Analysis: Lower systolic BP results <strong>in</strong> slower rates<strong>of</strong> decl<strong>in</strong>e <strong>in</strong> GFR <strong>in</strong> Diabetics and Non-DiabeticsSBP (mmHg)130 134 138 142 146 150 154 170 1800GFR ( (mL mL/m<strong>in</strong>/year)-2-4-6-8-10-12-14r = 0.69; P < .05UntreatedHTNParv<strong>in</strong>g HH, et al. Br Med J. 1989. Moschio G, et al. N Engl J Med. 1996.Viberti GC, et al. JAMA. 1993.Bakris GL, et al. Kidney Int. 1996.Klahr S, et al. N Eng J Med. 1994. Bakris GL. Hypertension. 1997.Hebert L, et al. Kidney Int. 1994. The GISEN Group. Lancet. 1997.Lebovitz H, et al. Kidney Int. 1994.Bakris GL, et al. Am J Kidney Dis. 2000;36(3):646-661.661.